In 2023, the sold production of ozone therapy, oxygen therapy, aerosol therapy, and respiration apparatus in Germany was 1.58 billion euros. Forecasts indicate growth in this sector, with production expected to reach 1.74 billion euros in 2024. The year-on-year variation is estimated at approximately 9.8% in 2025, maintaining a steady upward trajectory through 2028 with a consistent compound annual growth rate (CAGR) of about 8.1% over the five-year period.
Future trends to watch for in this sector include advancements in therapeutic technologies, increasing demand for at-home respiratory devices, and the influence of regulatory changes on production and market dynamics. Sustainability measures and digital health integration will also be pivotal in shaping the market landscape.
